BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.

Looking exhausted and relieved, the Silk Road founder said his release feels "amazing"—and that he now plans to spend time ...

Most of the major cryptocurrencies are in the green Friday morning, including Bitcoin and Dogecoin, but Trump's Solana token ...

The Dividend Kings underperformed in 2024. Read here to know about the top 18 most opportune Dividend Kings based on ...

Ludvig Aberg and Lanto Griffin shared the lead Thursday at Torrey Pines in the Farmers Insurance Open after ferocious wind forced an 86-minute delay and prevented dozens of players from finishing the ...

BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...

S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...

Shares of Becton Dickinson & Co. BDX shed 1.02% to $237.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,086 ...

In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...